Nyrada (NYR (:ASX) Investor Relations Material

Overview

Nyrada Inc is a new pharmaceutical company based in Australia, focused on drug discovery and development for cardiovascular and neurology conditions. The company is focused on tackling diseases and conditions that affect a large number of individuals, where current treatment options are inadequate or non-existent. Nyrada's clinical targets reflect significant community needs, and the company is poised to make a significant impact in the healthcare industry, particularly in the areas of cardiovascular and neurology.

Frequently Asked Questions

What is Nyrada's ticker?

Nyrada's ticker is NYR (

What exchange is Nyrada traded on?

The company's shares trade on the ASX stock exchange

Where are Nyrada's headquarters?

They are based in Gordon, Australia

How many employees does Nyrada have?

There are 1-10 employees working at Nyrada

What is Nyrada's website?

It is http://www.nyrada.com

What type of sector is Nyrada?

Nyrada is in the Healthcare sector

What type of industry is Nyrada?

Nyrada is in the Biotechnology industry

Who are Nyrada's peers and competitors?

The following five companies are Nyrada's industry peers:

- MacroGenics

- argenx SE

- Champions Oncology

- Cynata Therapeutics Limited

- Catalyst Biosciences, Inc.